Back to discover
Drug

alpha-Linolenic Acid

In clinical development
Emerging researchLate-stage development
Also known as ALA, LINOLENIC ACID, Octadecatrienoic acid, Alpha linolenic acid+8 more

ALA, LINOLENIC ACID, Octadecatrienoic acid, Alpha linolenic acid, (9,12,15)-linolenic acid, (9Z,12Z,15Z)-Octadecatrienoic acid, (Z,Z,Z)-9,12,15-octadecatrienoic acid, 9,12,15-Octadecatrienoic acid, 9-cis,12-cis,15-cis-octadecatrienoic acid, all-cis-9,12,15-Octadecatrienoic acid, cis,cis,cis-9,12,15-Octadecatrienoic acid, cis-delta(9,12,15)-Octadecatrienoic acid.

1
Research papers
1
Active clinical trials
Latest activity
beta

Recent clinical, regulatory, research and industry developments relating to this drug.

Profile

Identifiers & mechanism

Canonical identifiers, marketed brand names and mechanism, resolved across RxNorm, ChEMBL and ATC.

Canonical name
alpha-Linolenic Acid
Aliases & brands
ALALINOLENIC ACIDOctadecatrienoic acidAlpha linolenic acid(9,12,15)-linolenic acid(9Z,12Z,15Z)-Octadecatrienoic acid(Z,Z,Z)-9,12,15-octadecatrienoic acid9,12,15-Octadecatrienoic acid9-cis,12-cis,15-cis-octadecatrienoic acidall-cis-9,12,15-Octadecatrienoic acidcis,cis,cis-9,12,15-Octadecatrienoic acidcis-delta(9,12,15)-Octadecatrienoic acid
RxNorm CUI
52071
ChEMBL ID
CHEMBL8739
UNII
0RBV727H71

Clinical trials

5 trials

The current development programme across all trial phases — status mix, phase distribution and the late-stage studies shaping the evidence base.

Development programme
CLINICALTRIALS.GOV · LIVE REGISTRY
5
registered trials across all phases
LATEST COMPLETION 2023
1
Active studies
3
Late-stage (III+)
2
Completed
2
Discontinued
PHASE DISTRIBUTIONn = 5
Phase 22Phase 31Phase 41Phase N / A1

Research activity

1 papers

Key research shaping understanding of this drug, combining the latest publications with the most influential evidence.

Major research themes2
alpha-Linolenic Acid1Metabolic Syndrome1
Journals, researchers & institutions
Top journals
  • International journal of molecular sciences1
Leading researchers
  • Girek Z1
  • Jovanović P1
  • Jovanović V1
  • Pavlović S1
  • Ranković S1
  • Šarac I1
  • Takić M1
Leading institutions
free-text, unnormalised
  • Centre of Research Excellence in Nutrition and Metabolism1
  • Department of Biochemistry and Centre of Excellence for Molecular Food Sciences1
References & data sources
  • RxNorm (U.S. National Library of Medicine) — drug identity
  • ChEMBL (EMBL-EBI) & UniProt — pharmacology and targets
  • Europe PMC — research literature
  • ClinicalTrials.gov — clinical trials